Brief: PLx Pharma Reports Q4 Earnings Per Share Of $0.34
08/03/2019 12:01
March 8 (Reuters) - PLx Pharma Inc PLXP.O :
* . REPORTS FOURTH QUARTER 2018 RESULTS
* Q4 EARNINGS PER SHARE $0.34
* Q4 REVENUE $300,000
* REMAIN ON TRACK FOR MID-2020 LAUNCH OF VAZALORE
* REMAIN ON TRACK FOR MID-2020 LAUNCH OF VAZALORE
* AS OF DECEMBER 31, 2018, COMPANY HAD $14.3 MILLION IN CASH
AND
CASH EQUIVALENTS.
Source text for Eikon: ID:nGNX57Cv83
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice